MeSH term
Frequency | Condition_Probility | DNA-Binding Proteins/*genetics | 18 | 0.0 |
Humans | 53 | 0.0 |
*Mutation | 6 | 0.0 |
*Nerve Tissue Proteins | 61 | 13.0 |
*Repressor Proteins | 48 | 4.0 |
Research Support, Non-U.S. Gov't | 74 | 0.0 |
Transcription Factors/*genetics | 15 | 0.0 |
*Xenopus Proteins | 58 | 15.0 |
Animals | 77 | 0.0 |
Base Sequence | 20 | 0.0 |
Binding Sites | 7 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Gene Expression Regulation, Developmental | 17 | 1.0 |
Mice | 55 | 0.0 |
Mice, Mutant Strains | 17 | 2.0 |
Mice, Transgenic | 7 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Proteins/genetics/*metabolism | 3 | 0.0 |
Signal Transduction | 20 | 0.0 |
Telencephalon/*embryology | 2 | 40.0 |
Trans-Activators/genetics/metabolism | 4 | 2.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
*Zebrafish Proteins | 5 | 2.0 |
Child | 4 | 0.0 |
*Chromosome Deletion | 3 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Karyotyping | 2 | 0.0 |
Male | 18 | 0.0 |
Nerve Tissue Proteins/*genetics | 3 | 0.0 |
Syndactyly/*genetics | 5 | 38.0 |
DNA Primers | 2 | 0.0 |
Mice, Inbred C3H | 7 | 1.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 32 | 0.0 |
Abnormalities, Multiple/*genetics/pathology | 4 | 5.0 |
Disease Models, Animal | 4 | 0.0 |
Female | 16 | 0.0 |
Gene Targeting | 2 | 0.0 |
Hamartoma/*genetics | 3 | 27.0 |
Hypothalamic Diseases/*genetics/pathology | 2 | 100.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Mice, Knockout | 10 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Syndrome | 17 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
In Situ Hybridization | 13 | 0.0 |
Membrane Proteins/genetics/metabolism | 4 | 3.0 |
Pregnancy | 3 | 0.0 |
Proteins/metabolism | 7 | 0.0 |
Trans-Activators/genetics/*metabolism | 8 | 2.0 |
DNA-Binding Proteins/deficiency/genetics/*physiology | 4 | 16.0 |
Extremities/*embryology | 5 | 16.0 |
Feedback | 2 | 1.0 |
Gene Expression Regulation, Developmental/*physiology | 2 | 1.0 |
*Intercellular Signaling Peptides and Proteins | 3 | 0.0 |
Proteins/genetics/physiology | 2 | 3.0 |
Transcription Factors/deficiency/genetics/*physiology | 2 | 11.0 |
Zinc Fingers | 12 | 2.0 |
Alleles | 5 | 0.0 |
Epithelial Cells/metabolism | 3 | 0.0 |
Genotype | 4 | 0.0 |
Heterozygote | 3 | 0.0 |
Homozygote | 4 | 0.0 |
Phenotype | 13 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Trans-Activators/metabolism | 5 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Body Patterning | 4 | 6.0 |
Oncogene Proteins/*genetics | 4 | 2.0 |
Spinal Cord/embryology | 3 | 16.0 |
Chromosomes, Human, Pair 7 | 3 | 1.0 |
DNA-Binding Proteins/genetics | 6 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Transcription Factors/genetics | 7 | 0.0 |
Cell Differentiation | 5 | 0.0 |
Cell Division | 3 | 0.0 |
Central Nervous System/embryology | 2 | 11.0 |
Down-Regulation | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Abnormalities/*genetics | 2 | 18.0 |
Proteins/genetics/*physiology | 3 | 2.0 |
Sequence Deletion | 4 | 0.0 |
*Trans-Activators | 30 | 4.0 |
Gene Expression Regulation, Developmental/drug effects | 2 | 7.0 |
Rats | 4 | 0.0 |
Transcription Factors/genetics/*metabolism | 16 | 2.0 |
Cell Line | 6 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
*Transforming Growth Factor beta | 2 | 1.0 |
Comparative Study | 8 | 0.0 |
Genes, Homeobox | 2 | 2.0 |
Homeodomain Proteins/*genetics | 3 | 0.0 |
Oncogene Proteins/genetics | 3 | 4.0 |
Bone Morphogenetic Proteins/genetics | 2 | 6.0 |
Proteins/genetics | 6 | 0.0 |
Bone Morphogenetic Proteins/*metabolism | 2 | 4.0 |
Chick Embryo | 8 | 1.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Transcription Factors/*metabolism | 6 | 0.0 |
*Disease Models, Animal | 2 | 0.0 |
Limb Deformities, Congenital | 2 | 28.0 |
Amino Acid Sequence | 16 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Zinc Fingers/genetics | 5 | 2.0 |
Antigens, Differentiation | 2 | 2.0 |
*Body Patterning | 4 | 10.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Embryonic Induction | 5 | 15.0 |
Fibroblast Growth Factors/*metabolism | 2 | 5.0 |
Homeodomain Proteins/metabolism | 3 | 3.0 |
Oncogene Proteins/metabolism | 3 | 3.0 |
*Zinc Fingers | 6 | 2.0 |
Animals, Genetically Modified | 3 | 1.0 |
Drosophila/genetics | 2 | 1.0 |
*Drosophila Proteins | 9 | 0.0 |
Insect Proteins/metabolism | 3 | 20.0 |
Oncogene Proteins/genetics/metabolism | 6 | 18.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Repressor Proteins/genetics/*metabolism | 2 | 1.0 |
Species Specificity | 4 | 0.0 |
Body Patterning/physiology | 2 | 18.0 |
DNA, Complementary | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
*Gene Expression Regulation, Developmental | 13 | 2.0 |
*Signal Transduction | 4 | 0.0 |
COS Cells | 2 | 0.0 |
DNA-Binding Proteins | 3 | 3.0 |
Embryonic and Fetal Development | 4 | 1.0 |
Extremities/embryology | 2 | 5.0 |
Mutagenesis | 2 | 0.0 |
Oncogene Proteins/genetics/*metabolism | 4 | 8.0 |
Signal Transduction/*physiology | 3 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 2 | 1.0 |
Proteins/*metabolism | 7 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Transcription Factors/genetics/*physiology | 5 | 2.0 |
Body Patterning/*genetics | 3 | 15.0 |
Gene Deletion | 2 | 0.0 |
Hippocampus/embryology | 2 | 66.0 |
Proteins | 2 | 3.0 |
Tissue Distribution | 4 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 3 | 2.0 |
DNA-Binding Proteins/genetics/*metabolism | 10 | 1.0 |
Embryo/anatomy & histology/physiology | 2 | 8.0 |
Nerve Tissue Proteins/genetics/*metabolism | 2 | 1.0 |
Stem Cells/cytology/metabolism | 3 | 6.0 |
DNA, Complementary/genetics | 4 | 0.0 |
Drosophila melanogaster/embryology/*genetics/growth & development | 2 | 50.0 |
Genes, Reporter | 5 | 0.0 |
Genes, Synthetic | 2 | 3.0 |
Genetic Complementation Test | 2 | 0.0 |
Insect Proteins/genetics/*physiology | 2 | 25.0 |
Morphogenesis | 5 | 2.0 |
Oncogene Proteins/genetics/*physiology | 3 | 42.0 |
Proteins/physiology | 2 | 1.0 |
Recombinant Fusion Proteins/physiology | 2 | 0.0 |
Repressor Proteins/genetics/*physiology | 2 | 5.0 |
*Transcription, Genetic | 4 | 0.0 |
Wing/*embryology | 2 | 40.0 |
Adult | 3 | 0.0 |
Drosophila | 7 | 2.0 |
Fetus | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Oncogene Proteins/*metabolism | 2 | 2.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Hela Cells | 2 | 0.0 |
Embryo, Nonmammalian/metabolism | 2 | 5.0 |
Models, Biological | 2 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Chromosomes, Human, Pair 7/genetics | 2 | 2.0 |
Codon/genetics | 2 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Family Health | 2 | 0.0 |
Pedigree | 5 | 0.0 |
Craniofacial Abnormalities/*genetics | 3 | 9.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Transfection | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Multigene Family | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 4 | 1.0 |
Nervous System/embryology | 2 | 6.0 |
Fibroblast Growth Factors/genetics | 2 | 5.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
DNA-Binding Proteins/*genetics/*metabolism | 3 | 2.0 |
Embryonic Induction/*genetics | 3 | 33.0 |
Neurons/metabolism | 2 | 0.0 |
Proteins/genetics/metabolism | 3 | 1.0 |
Polydactyly/*genetics | 5 | 22.0 |
3T3 Cells | 2 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Body Patterning/genetics | 2 | 7.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Homeodomain Proteins/genetics/metabolism | 3 | 4.0 |
Polydactyly/genetics | 7 | 33.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Mesoderm/metabolism | 2 | 2.0 |
Transcription Factors/genetics/metabolism/*physiology | 2 | 3.0 |
*Embryonic Induction | 3 | 14.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Mutation | 12 | 0.0 |
Neurons/cytology | 3 | 6.0 |
Proteins/*genetics | 2 | 0.0 |
*Transcription Factors | 7 | 0.0 |
Xenopus laevis | 3 | 0.0 |
Abnormalities, Multiple/*genetics | 7 | 2.0 |
*Chromosomes, Human, Pair 7 | 4 | 1.0 |
Infant | 3 | 0.0 |
Limb Bud | 2 | 28.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Abnormalities, Multiple/genetics | 2 | 2.0 |
Polymorphism, Genetic | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 4 | 0.0 |
Zinc Fingers/*genetics | 7 | 3.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Limb Deformities, Congenital/genetics | 2 | 16.0 |
Models, Genetic | 2 | 0.0 |
Syndactyly/genetics | 2 | 22.0 |
DNA-Binding Proteins/*biosynthesis | 2 | 1.0 |
Oncogene Proteins/*biosynthesis | 3 | 17.0 |
*Protein Biosynthesis | 2 | 0.0 |
Toes/abnormalities | 2 | 28.0 |
Transcription Factors/*biosynthesis | 3 | 2.0 |
Crosses, Genetic | 2 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Mice, Inbred Strains | 3 | 0.0 |
Osteogenesis | 2 | 8.0 |
Chimera | 2 | 1.0 |
Restriction Mapping | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Abnormalities, Multiple/embryology/*genetics | 2 | 16.0 |
Bone and Bones/*abnormalities | 2 | 9.0 |
Skull/abnormalities | 2 | 14.0 |
*Gene Deletion | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
Morphogenesis/genetics | 2 | 5.0 |
RNA, Messenger/*analysis | 2 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Facial Bones/*abnormalities | 2 | 14.0 |
Corpus Callosum/*abnormalities | 2 | 40.0 |
Polydactyly/*pathology | 2 | 66.0 |
Body Patterning/*physiology | 2 | 11.0 |
Embryonic Induction/*physiology | 2 | 50.0 |
Neurons/physiology | 2 | 1.0 |
Repressor Proteins/genetics/metabolism | 3 | 3.0 |
Spinal Cord/*embryology | 2 | 50.0 |
*Receptors, G-Protein-Coupled | 2 | 0.0 |
